AZ files immunotherapy Imfinzi in Europe – PharmaTimes – PharmaTimes
|
AZ files immunotherapy Imfinzi in Europe – PharmaTimes
PharmaTimes AstraZeneca has submitted the first marketing application in Europe for its immunotherapy Imfinzi, seeking approval for the drug's use to treat a subset of patients … |
